Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 3/2009

01-03-2009 | Research Articles

The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients

Authors: Juan Ignacio Arraras, Elena Villafranca, Fernando Arias de la Vega, Pilar Romero, Mikel Rico, Meritxell Vila, Gemma Asín, Volker Chicata, Miguel Ángel Domínguez, Nuria Lainez, Ana Manterola, Enrique Martínez, Maite Martínez

Published in: Clinical and Translational Oncology | Issue 3/2009

Login to get access
Metadata
Title
The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients
Authors
Juan Ignacio Arraras
Elena Villafranca
Fernando Arias de la Vega
Pilar Romero
Mikel Rico
Meritxell Vila
Gemma Asín
Volker Chicata
Miguel Ángel Domínguez
Nuria Lainez
Ana Manterola
Enrique Martínez
Maite Martínez
Publication date
01-03-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 3/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/S12094-009-0332-z

Other articles of this Issue 3/2009

Clinical and Translational Oncology 3/2009 Go to the issue

Case Reports

Acute ischaemic cerebrovascular attack secondary to infusional 5-fluoruracil and cisplatin in a patient with advanced gastric cancer

Case Reports

Primary non-Hodgkin lymphoma and invasive ductal carcinoma in the same breast: a rare case report

Reviews

New approaches to female fertility preservation

Research Articles

Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?

News and Views

What a strange thing it is to live

Editorial

Beware the node: the more we know, the less aggressive we are

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits